|
|
| Epilepsy Clinical Trial |
 This study is ongoing, but not recruiting participants.
Medtronic, Inc. is sponsoring an investigational study of the Intercept™ Epilepsy Control System, the company's deep brain stimulation therapy for patients with refractory epilepsy. Epilepsy is a condition that affects 2.3 million Americans, and about one-third of these patients are refractory, or continue to experience seizures despite a wide range of treatment options.
|
|
| Company Description |
Medtronic is a medical technology company focused on chronic disease. With roots in the treatment of heart disease, Medtronic now provides a wide range of products and therapies.
|
| Founded |
April 29, 1949, in
Minneapolis, Minnesota,
USA
|
| Global Presence |
Medtronic does business in more than 120 countries and has scientific, manufacturing, education and sales facilites worldwide. Regional Headquarters are based in Switzerland and Japan.
|
 |
|
|
Caution: Investigational device. Limited by US law to investigational use only. |
Privacy Statement
Email This Page